Sun Pharma extends rally on EIR from USFDA for Halol facility

The stock was up 4% to Rs 561 on BSE in early morning trade, extending its past five days 14% rally, after the company announced the resolution of regulatory compliance issues at Halol plant.

from Latest News https://ift.tt/2y90deE

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 12:37 pm Tags : Latest News

Subscribe by Email

Follow Updates Articles from This Blog via Email